Outcomes of combined trabecular micro-bypass and phacoemulsification in a predominantly Hispanic patient population
Authors:
Open Access
- 1 October 2016
- journal article
- research article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 10, 1931-1937
Abstract
Purpose: The purpose of this study was to evaluate intraocular pressure (IOP) and topical ocular hypotensive medication burden at 12 months postoperatively in a predominantly Hispanic patient population with primary open-angle glaucoma each implanted with one trabecular micro-bypass stent during cataract surgery. Methods: This was a retrospective, consecutive case series. The main objective was to assess reduction of IOP and/or medication burden in all eyes at the 12-month postoperative exam. A secondary objective was to assess outcomes in 3 subgroups, distinguished preoperatively by IOP control and by medication burden (suboptimal or maximum therapy) and with different treatment goals. Group 1 had medication-controlled IOP and goal to reduce medications while maintaining IOP control (n=65); Group 2 had uncontrolled IOP on ≤2 medications and goal to reduce IOP and maintain/reduce medication burden (n=31); and Group 3 had uncontrolled IOP on ≥3 medications and goal to reduce IOP and avoid filtering surgery (n=38). Evaluations included IOP, medication use, cup-to-disc ratio, visual fields, complications, and interventions. One hundred subjects (134 eyes) have been followed for 12 months. Results: Most patients (80%) were Hispanic and had moderate or severe glaucoma (87%). At 12 months, mean IOP reduced to 12.9 mmHg vs 16.5 mmHg preoperatively; 92% had an IOP ≤15 mmHg at 12 months (99% had ≤18 mmHg). Mean medication burden had decreased to 0.9 vs 2.3 preoperatively. At the 12-month time point, 94% of all eyes achieved their predefined treatment goal of reduced IOP and/or medications. Reductions in medication burden for Group 1, and in IOP for Groups 2 and 3, were highly statistically significant (PConclusion: This mainly Hispanic population with predominantly moderate or severe glaucoma had substantial reduction of IOP and medication and favorable safety for 12 months following stent implantation during cataract surgery, with treatment success achieved in all 3 subgroups. These data show this stent technology to be effective in Hispanic eyes with more advanced disease.Keywords
This publication has 18 references indexed in Scilit:
- GlaucomaThe Lancet, 2011
- Randomized Evaluation of the Trabecular Micro-Bypass Stent with Phacoemulsification in Patients with Glaucoma and CataractOphthalmology, 2011
- Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucomaJournal of Cataract & Refractive Surgery, 2010
- Glaucoma and Systemic DiseasesSurvey of Ophthalmology, 2010
- Determinants of Adherence to Glaucoma Medical Therapy in a Long-term Patient PopulationJournal of Glaucoma, 2009
- Adherence and Persistence with Glaucoma TherapySurvey of Ophthalmology, 2008
- Glaucoma in the United States and EuropeJournal of Glaucoma, 2007
- Does Adjunctive Glaucoma Therapy Affect Adherence to the Initial Primary Therapy?Ophthalmology, 2005
- Prevalence of open-angle glaucoma and ocular hypertension in LatinosOphthalmology, 2004
- The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deteriorationAmerican Journal of Ophthalmology, 2000